From the Aiosyn Blog IVDR represents a significant overhaul of regulations requiring more rigorous oversight, clinical validation assessed by a Notified Body, and stricter post-market surveillance (PMS). Aiosyn’s AI-powered...

Nijmegen, the Netherlands –  Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its algorithm for mitotic figure counting has achieved CE marking under the In Vitro Diagnostic...

From the Aiosyn blog: In the ever-changing landscape of pathology, the accurate assessment of mitotic activity plays a crucial role in diagnosing and managing various diseases, including cancer. Traditionally, pathologists manually count...